新闻/Reuters/CMS Grants Fresenius Kabi Permanent, Product-Specific Q-Code For Conexxence And BomyntraCMS Grants Fresenius Kabi Permanent, Product-Specific Q-Code For Conexxence And BomyntraRefinitiv阅读少于1分钟Fresenius Kabi Oncology Ltd (FRES.M3):CMS GRANTS FRESENIUS KABI PERMANENT, PRODUCT-SPECIFIC Q-CODE FOR CONEXXENCE® AND BOMYNTRA® (DENOSUMAB-BNHT)Reuters亚洲© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html显示更多登录或创建永久免费帐户以阅读此新闻我们开始吧
